Tradestie Institutional Equity Comparison Engine
AAME vs MURA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AAME Overall Edge
AAME Captures Institutional Edge (2โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Atlantic American Corp (AAME) driven by superior Valuation, Growth & Margin while MURA counters with relative strength in Momentum & Technical. Fundamentally, AAME trades at 7.4x Forward P/E with 5.1% operating margin (+4.8% YoY revenue) versus MURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAME sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MURA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AAME
AAME 7.4x vs MURA N/M Fwd P/E
Growth & Margin Winner
AAME
Op Margin 5.1% vs 0.0% ยท YoY +4.8% vs +0.0%
Momentum & Technical Winner
MURA
1Y -60.9% vs -51.4% ยท 52W Pos 8% vs 28%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AAME
NASDAQ
Atlantic American Corp
Life Insurance
$1.18
-6.35% 1D
Market Cap
$25.7M
1M Return
+12.38%
1Y Return
-60.93%
Forward P/E
7.4x
Unified AI Score
42.1 / 100
HOLD
Tech 45.0
Fund 49.0
Flow 50.0
Mom 60.0
MURA
NASDAQ
Mural Oncology plc Ordinary Shares
Pharmaceutical Preparations
$2.03
+0.0% 1D
Market Cap
$35.0M
1M Return
-2.4%
1Y Return
-51.44%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 25.0
Fund 36.0
Flow 50.0
Mom 35.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AAME -60.93%
MURA -51.44%
Spread: +15.34 pp (MURA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AAME TTM Op. Margin: 5.1%
MURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAME vs MURA. Trailing 12-month operating profitability (AAME 5.1% vs MURA 0.0%) and valuation multiples (AAME 7.4x vs MURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AAME | MURA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $25.7M | $35.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 4.5x | N/M | Lower Multiple | AAME |
| Forward P/E Ratio Valuation | 7.4x | N/M | Lower Multiple | AAME |
| Revenue Growth (YoY) Growth | +4.8% | +0.0% | Higher Growth | AAME |
| Operating Margin (TTM) Profitability | 5.1% | 0.0% | Higher Margin | AAME |
| Net Profit Margin Profitability | 2.9% | 0.0% | Higher Margin | AAME |
| Return on Equity (ROE) Capital Efficiency | 5.2% | -103.9% | Higher ROE | AAME |
| 52-Week Range Position Momentum | 8% ($1โ$3) | 28% ($1โ$5) | Stronger Trend | MURA |
| Beta / 30D Volatility Risk Regime | 0.92ฮฒ ยท 116% Vol | 0.39ฮฒ ยท 16% Vol | Lower Realized Risk | MURA |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 44.8 / 100 (HOLD) | Higher Composite | MURA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AAME vs MURA Buy Guide
AAME
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MURA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AAME nor MURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.